7.15 million common shares sold by BofA, Credit Suisse and Jefferies
By Devika Patel
Knoxville, Tenn., April 12 - Durata Therapeutics, Inc. said it priced a $50.05 million public sale of stock with a $7.51 million greenshoe.
The company will sell 7.15 million common shares at $7.00 per share. The price per share is a 3.85% discount to the April 11 closing share price of $7.28.
BofA Merrill Lynch, Credit Suisse Securities (USA) LLC and Jefferies LLC are the joint bookrunning managers.
Settlement is expected April 17.
The pharmaceutical company is based in Morristown, N.J.
| Issuer: | Durata Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $50.05 million
|
| Greenshoe: | $7,507,500
|
| Shares: | 7.15 million
|
| Price: | $7.00
|
| Warrants: | No
|
| Bookrunners: | BofA Merrill Lynch, Credit Suisse Securities (USA) LLC and Jefferies LLC
|
| Co-managers: | JMP Securities LLC and RBC Capital Markets, LLC
|
| Pricing date: | April 12
|
| Settlement date: | April 17
|
| Stock symbol: | Nasdaq: DRTX
|
| Stock price: | $7.28 at close April 11
|
| Market capitalization: | $132.88 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
